PATENT CLAIM ANALYSIS

Application Number: 16100349
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "093400"]

Abstract:
The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.

Claim (Index 40):
The method of  claim 36 , wherein said administering is further effective to reduce the level of IL-17A, IL-17B, IL-17C, IL-17D, IL-17E, IL-17F, IFN-\u03b3, IL-10, or TNF\u03b1 relative to the level of IL-17A, IL-17B, IL-17C, IL-17D, IL-17E, IL-17F, IFN-\u03b3, IL-10, or TNF\u03b1 before said subject is administered said pharmaceutical composition.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.06667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15679857', '15592178', '15673270', '16040356', '15842635']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7843868563150608
- 35 USC 102 Novelty (BERT): 0.7014846910176675
- Combined Prediction Score: 0.7760966397853215
- Mean Citation Score: 690.07265
- Max Citation Score: 808.12335
- Similarity Product: 708.5685266397268

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test